Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Recreational golf can be lonely without community; this Olathe-built app brings players together on the green
He set out to create an all-encompassing, tech-enabled golf platform that would make his favorite sport more fun, accessible, convenient, and transparent — but Somanath Chilukuri already knew the hazards of the crowded course ahead of him. “Today there is so much app overload on people,” said Chilukuri, an Olathe IT professional and the founder…
$2M federal grant boosts K-State efforts to expand region’s digital manufacturing capabilities
Startland News’ Startup Road Trip series explores innovative and uncommon ideas finding success in rural America and Midwestern startup hubs outside the Kansas City metro. This series is possible thanks to the Ewing Marion Kauffman Foundation, which leads a collaborative, nationwide effort to identify and remove large and small barriers to new business creation. MANHATTAN,…
Yardball Kickstarter ends with six-figure funding (and rapid hiring for production)
When Sandlot Goods took to Kickstarter to crowdfund what it called “the perfect ball for the game of catch,” the world listened. More than 2,200 backers from across the globe pledged funds to secure their own Yardball — lighter than a baseball and sewn by hand with soft, premium leather. “We are absolutely thrilled with…
Allyship means mistakes plus action: New project draws parallels between innovation, DEIB
It’s time for coworkers to move beyond best intentions, said Ghadeer Garcia and Mark Logan, announcing the launch of a new project aimed at pushing allies in the workplace to action. The co-founders created the Ally Lab project through Idealect, an equity-centered social innovation company in Kansas City. The Ally Lab will offer knowledge and…